1. The Fed and Monetary PolicyMonetary policy is the action taken by the Federal Reserve to expand or contract the money supply and influence interest rates. After checking the current news on monetary policy, describe the Fed's current policy - is it expanding or contracting the money supply, and why? Do you think that this policy could increase or reduce inflation?2. Inflation - Winners and LosersWe often hear of inflation characterized as a bad thing, but Meyer describes both winners and losers from inflation. Give an example of one way in which you would win from unexpected inflation, and an example of one way in which you would lose from unexpected inflation.

-Topic: Anxiety- 2 pages- Apa Format-5 References-attatch 3 PDF ReferencesAssignment 1: Prescribing for Children and AdolescentsOff-label prescribing is when a physician gives you a drug that the U.S. Food and Drug Administration (FDA) has approved to treat a condition different than your condition. This practice is legal and common. In fact, one in five prescriptions written today are for off-label use.—Agency for Healthcare Research and QualityPhoto Credit: Getty Images/Ingram PublishingPsychotropic drugs are commonly used for children and adolescents to treat mental health disorders, yet many of these drugs are not FDA approved for use in these populations. Thus, their use is considered “off-label,” and it is often up to the best judgment of the prescribing clinician. As a PMHNP, you will need to apply the best available information and research on pharmacological treatments for children in order to safely and effectively treat child and adolescent patients. Sometimes this will come in the form of formal studies and approvals for drugs in children. Other times you may need to extrapolate from research or treatment guidelines on drugs in adults. Each individual patient case will need to be considered independently and each treatment considered from a risk assessment standpoint. What psychotherapeutic approach might be indicated as an initial treatment? What are the potential side effects of a particular drug?For this Assignment, you consider these questions and others as you explore FDA-approved (“on label”) pharmacological treatments, non-FDA-approved (“off-label”) pharmacological treatments, and nonpharmacological treatments for disorders in children and adolescents.Reference:Agency for Healthcare Research and Quality. (2015). Off-label drugs: What you need to know. https://www.ahrq.gov/patients-consumers/patient-involvement/off-label-drug-usage.htmlTo PrepareYour Instructor will assign a specific disorder for you to research for this Assignment.Use the Walden library to research evidence-based treatments for your assigned disorder in children and adolescents. You will need to recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating this disorder in children and adolescents.The Assignment (2 pages)Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating your assigned disorder in children and adolescents.Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?Explain whether clinical practice guidelines exist for this disorder and, if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.Support your reasoning with at least three scholarly resources, one each on the FDA-approved drug, the off-label, and a non-medication intervention for the disorder. Attach the PDFs of your sources.-Learning ResourcesRequired Readings (click to expand/reduce)Hilt, R. J., & Nussbaum, A. M. (2016). DSM-5 pocket guide for child and adolescent mental health. American Psychiatric Association Publishing. Chapter 14, “Psychosocial Interventions”Chapter 15, “Psychotherapeutic Interventions”Chapter 16, “Psychopharmacological Interventions”Thapar, A., Pine, D. S., Leckman, J. F., Scott, S., Snowling, M. J., & Taylor, E. A. (2015). Rutter’s child and adolescent psychiatry (6th ed.). Wiley Blackwell. Chapter 43, “Pharmacological, Medically-Led and Related Treatments”Walden University. (n.d.). Developing SMART goals. https://academicguides.waldenu.edu/ld.php?content_... Zakhari, R. (2020). The psychiatric-mental health nurse practitioner certification review manual. Springer. Chapter 5, “Psychopharmacology”Required Media (click to expand/reduce)CriticalThinkRx. (2019, June 9). Module 5: Specific drug classes: Focus on adverse effects [Video]. YouTube. https://youtu.be/Gbq6RnOsGKQCriticalThinkRx. (2019, June 9). Module 2: Use of psychotropics with youth_prevalence and concerns [Video]. YouTube.